Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Corbus Pharmaceuticals updated its corporate investor presentation to highlight its clinical pipeline in oncology and obesity. Key focus areas include the CRB-701 Nectin-4 ADC, which is entering a registrational Phase 2 study for OPSCC, and CRB-913, a CB1 inverse agonist for obesity with a Phase 2 study expected to start in the first half of 2027.
Quaint Oak Bancorp, Inc. declared a quarterly cash dividend of $0.04 per share. The dividend is payable on November 9, 2026, to shareholders of record as of October 26, 2026.
Federal Home Loan Bank of Dallas $100M Debt Financing with Office of Finance
The Federal Home Loan Bank of Dallas committed to issuing $100 million in consolidated obligation bonds as the primary obligor. These debt securities are joint and several obligations of the 11 Federal Home Loan Banks and are sold through the Office of Finance to fund the Bank's operations. The specific bond issued is a non-callable variable/single index floater maturing on January 15, 2027.
Main Street Capital announced preliminary financial estimates for the third quarter of 2026, including expected net asset value (NAV) per share between $34.18 and $34.26. The company also estimated distributable net investment income (DNII) of $0.94 to $0.98 per share and reported that non-accrual investments represent approximately 0.9% of the portfolio at fair value.
iPower Inc. announced that its subsidiary, iPower AI LLC, received a customer-signed, non-binding letter of intent for a five-year AI equipment services and management relationship. The deal contemplates an expansion from 48 to 396 AI computing units, potentially generating up to $21.90 million in annualized service fees.
bioAffinity Technologies announced it will present positive research data at the CHEST 2026 annual meeting regarding its CyPath Lung test and a new investigational test for asthma and COPD-related lung inflammation. The presentation will focus on improving lung cancer risk stratification and managing pulmonary nodules using the company's noninvasive flow cytometry technology.
Sinda Ltd. announced the departure of CFO Luis Barreto and the appointment of Scott Cole as Interim Chief Financial Officer. Additionally, the company expanded its Board of Directors to nine members and appointed Alberto C. Zinser as a new director.
Pineapple Financial (rebranding as Pentiv) appointed Usman Maher, a former SoFi executive, as Chief Financial Officer and Chief Strategy Officer effective October 15, 2026. Former CFO Syed Sarfraz Habib will transition to the role of Chief Accounting Officer and Controller following the filing of the company's annual report. The leadership change coincides with the launch of the Pentiv intelligence platform for mortgage brokerages.
Evolution Metals & Technologies Corp. has begun taking delivery of 13 ULVAC machines at its Pohang, South Korea facility, part of a 57-container shipment to expand production. The expansion is expected to increase the company's annual rare earth magnet capacity ten-fold from 1,000 to 10,000 metric tons. This move positions EM&T as the largest producer of rare earth permanent magnets outside of China ahead of new U.S. defense procurement regulations.
Aflac Insider Japan Post Holdings Co. Ltd. Sells $4.89M of Stock
Japan Post Holdings Co. Ltd. sold 42,000 shares of Aflac Inc at $116.37 to $117.03 a share (average $116.38) in 2 transactions, worth $4.89M in total on Oct 13, 2026. Shares held after the trade: 50,302,940 (-0.0%).
Alpha Digital Voltz Inc. reported a net loss of $368,547 for the quarter ended August 31, 2026, primarily driven by professional fees following a change in control and shift in business focus to AI infrastructure. The company reported zero cash on hand and an accumulated deficit of $409,169, raising substantial doubt about its ability to continue as a going concern.
Prologis, Inc. reported third quarter 2026 financial results with total revenues of $2.39 billion and Net Earnings of $816 million. The company's Core FFO per share increased to $1.66 compared to $1.53 in the prior year period, driven by strong performance in its global logistics real estate portfolio.
Velo3D announced preliminary unaudited revenue for the third quarter of 2026, expecting a range of $19.5 million to $20.5 million. This represents year-over-year growth of approximately 43% to 51% compared to the same period in 2025. The company plans to release its full financial results during the week of November 9, 2026.
Quantum-Si Incorporated has regained compliance with Nasdaq's minimum bid price requirement as its Class A common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days. The company had previously received a deficiency notice on July 23, 2026, and Nasdaq has now officially closed the matter.
Edesa Biotech announced that the FDA has cleared its Investigational New Drug (IND) application for a Phase 2 clinical study of EB06 in vitiligo. This clearance allows the company to expand patient recruitment into the United States, with topline data expected in the fourth quarter of 2027.
Youlife Group Inc. reported a 114.8% year-over-year revenue increase to RMB1,961.9 million for the first half of 2026, driven by the acquisition of YouheHR and growth in employee management services. While gross profit rose 31.7%, gross margin compressed from 14.1% to 8.6% due to the lower-margin profile of the newly acquired business and increased R&D investment in AI-enabled platforms.
SenesTech announced record preliminary revenue of approximately $1.1 million for the third quarter of 2026, marking the first time the company has exceeded the $1 million quarterly threshold. This represents 40% sequential growth over Q2 2026 and 55% year-over-year growth, driven by scaling e-commerce and B2B traction.
Super Micro Computer appointed Mark Long as Chief Financial Officer, effective October 14, 2026, succeeding David Weigand. Mr. Long, a former CFO of Western Digital, will receive an annual base salary of $725,000, a $500,000 sign-on bonus, and an initial equity grant of 120,000 RSUs and 150,000 stock options.
Global Ship Lease Chief Compliance Officer Georgios Giannopoulos Sells $347K of Stock
Georgios Giannopoulos, Chief Compliance Officer, sold 7,692 shares of Global Ship Lease, Inc. at $45.08 a share, worth $347K in total on Oct 13, 2026. Shares held after the trade: 0 (-100.0%).
Borr Drilling Insider Tor Olav Troim Buys $3.54M of Stock
Tor Olav Troim bought 750,000 shares of Borr Drilling Ltd at $4.72 a share, worth $3.54M in total on Oct 14, 2026. Shares held after the trade: 39,617,808 (+1.9%).
Claritev Corporation has appointed Jennifer Main to its Board of Directors, effective October 15, 2026, increasing the board size from 11 to 12 members. Ms. Main, who currently serves as CFO of RealMDai and Overture Life and previously served as COO of the Centers for Medicare & Medicaid Services (CMS), will serve as a Class II director and a member of the Audit Committee.
NeoVolta Insider John A. Hass Buys $65.2K of Stock
John A. Hass bought 25,000 shares of NeoVolta Inc. at $2.61 a share, worth $65.2K in total on Sep 30, 2026. Shares held after the trade: 126,190 (+24.7%).
Beazer Homes USA M&A Deal with Dream Finders Homes, Inc.
Beazer Homes USA stockholders approved the previously announced merger agreement with Dream Finders Homes, Inc. at a special meeting held on October 15, 2026. Under the terms of the agreement, Beazer Homes will become a wholly owned subsidiary of Dream Finders Homes, with the closing expected to occur three business days after final conditions are met.
Recursion Pharmaceuticals entered into an underwriting agreement to raise approximately $200 million through a public offering of 61,540,000 shares of Class A common stock at $3.25 per share. The company also announced that Sanofi exercised an option for a first-in-class immunology development candidate under their existing collaboration, triggering a $10 million milestone payment. Proceeds from the equity raise are expected to extend the company's cash runway into 2029.
Vivos Therapeutics Signs $12M M&A Deal with SOD Sciences, Inc.
Vivos Therapeutics entered into a definitive agreement to acquire an 11% equity stake in SOD Sciences and a 50% co-ownership interest in a proprietary pseudohypoxia early-warning test. The transaction is valued at $12 million, paid via the issuance of 12,000 shares of newly created Series C Convertible Preferred Stock, and is intended to bolster stockholders' equity for Nasdaq compliance.
AtlasClear Holdings Signs $24.5M M&A Deal with Ark Financial Services, Inc.
AtlasClear Holdings has entered into a definitive agreement to acquire Ark Financial Services, the parent of investment bank Dawson James Securities, for up to $24.5 million in cash and stock. The company concurrently completed an initial 24.9% equity purchase for $5 million, with the remaining 75.1% acquisition subject to FINRA approval and other closing conditions. The deal aims to integrate a nationally ranked small-cap investment bank into AtlasClear's clearing platform, more than doubling the company's combined pro forma revenue.
DeFi Development Corp. announced an increase in the annual dividend rate for its Variable Rate Series C Perpetual Preferred Stock (CHAD) from 13.00% to 14.00%. The company declared daily cash dividends of $0.00614 per share for each business day in November 2026, totaling approximately $0.184 million for the month.
Craig Conti has resigned as Executive Vice President and Chief Financial Officer of Verra Mobility, effective November 4, 2026, to pursue an opportunity in a different industry. The company has initiated a search for a successor with Spencer Stuart and expects to appoint an interim CFO. The departure is not related to any disagreements regarding financial or operational results.
“I am grateful for Craig’s leadership, partnership and contributions to the Company. On behalf of all of us at Verra Mobility, I wish him well in his next chapter.”
Jon Keyser, Interim President and CEO of Verra Mobility
Conduent Debt Financing Update with Bank of America, N.A.
Conduent Incorporated entered into Amendment No. 4 to its existing Credit Agreement to extend the maturity date of revolving credit commitments from October 15, 2026, to October 30, 2026. The short-term extension is intended to provide additional time for the company and its lenders to finalize a broader refinancing of its revolving credit facilities.
Our Bond, Inc. announced a 1-for-20 reverse stock split of its common stock, which will become effective in the market on October 19, 2026. The split will reduce the number of outstanding shares from approximately 32.6 million to approximately 1.6 million to consolidate share count and increase the per-share price.